A Study of Ponesimod in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 18, 2022

Primary Completion Date

March 5, 2023

Study Completion Date

March 29, 2023

Conditions

Healthy

Interventions

DRUG

Ponesimod

Ponesimod tablet will be administered orally.

DRUG

Carbamazepine

Carbamazepine tablet will be administered orally.

Trial Locations (1)

Clinical Pharmacology Unit, Merksem

All Listed Sponsors

lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY